Clinical studies of 5-HT function using i.v. L-tryptophan

Area of Science:

• Neuropharmacology
• Psychiatry
• Neuroscience

Background:

• Antidepressant treatment alters serotonergic (5-HT) receptor sensitivity.
• Abnormal brain 5-HT function is implicated in depression.
• Pharmacological challenge is a key clinical study method.

Purpose of the Study:

• To assess brain 5-HT function using intravenous L-tryptophan (L-TRP) challenge.
• To investigate the prolactin (PRL) response to L-TRP in depression and other disorders.
• To examine the effects of antidepressants on the L-TRP-induced PRL response.

Main Methods:

• Intravenous L-tryptophan (L-TRP) administration.
• Measurement of serum prolactin (PRL) response as a marker of 5-HT function.
• Comparison of PRL response in depressed patients, other psychiatric disorders, and healthy controls.
• Assessment of drug effects (TCAs, MAOIs, SSRIs, lithium, atypical antidepressants, benzodiazepines) on PRL response.

Main Results:

• The PRL response to L-TRP is blunted in depressed patients compared to controls.
• This blunting is specific to depression, not observed in panic disorder, OCD, or schizophrenia.
• Certain antidepressants (TCAs, MAOIs, SSRIs, lithium) enhance the PRL response in a time-dependent manner.
• Atypical antidepressants and benzodiazepines do not affect the PRL response.

Conclusions:

• The blunted PRL response to L-TRP suggests impaired net 5-HT function in depression.
• Antidepressant action might be better understood as 5-HT dependent rather than solely 5-HT enhancing.
• Further research with selective 5-HT drugs can elucidate mechanisms in neuropsychiatric disorders.